Elisa Z. Ramirez
Elisa Z. Ramirez's purchase track record
How the stock did after each of Elisa Z. Ramirez's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/9/2025 | CCS | $77K | +13.3% | +12.1% | +18.9% |
| 4/28/2025 | CCS | $81K | +9.9% | +18.1% | +24.3% |
| 5/24/2023 | PFIS | $4K | +12.6% | +8.9% | +10.7% |
| 2/2/2023 | PFIS | $21K | -27.5% | -10.3% | +7.7% |
| 9/16/2022 | PFIS | $25K | +8.7% | -12.8% | +1.1% |
| 3/8/2022 | PFIS | $50K | +10.9% | +3.9% | -6.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
PFIS highlighted in Yahoo Finance article. A recent Yahoo Finance article titled 'Peoples Financial Services (PFIS) Could Be a Great Choice' has drawn attention to the stock. The piece appears to focus on the company's current valuation and income potential, rather than reporting on a specific corporate event or earnings release. This type of media coverage often reflects broader market sentiment toward dividend-paying financial stocks.
Transaction History
| CCS | ▲ Buy | Grant | 3,225 | $0 | 5/6/2026 | View on chart |
| PFIS | ▲ Buy | Grant | 297 | $0 | 1/30/2026 | View on chart |
| CCS | ▲ Buy | Open Market | 400 | $22K | 5/12/2025 | View on chart |
| CCS | ▲ Buy | Open Market | 500 | $27K | 5/9/2025 | View on chart |
| CCS | ▲ Buy | Open Market | 500 | $27K | 5/9/2025 | View on chart |
| CCS | ▲ Buy | Grant | 3,286 | $0 | 5/7/2025 | View on chart |
| CCS | ▲ Buy | Open Market | 1,500 | $81K | 4/28/2025 | View on chart |
| PFIS | ▲ Buy | Grant | 280 | $0 | 1/31/2025 | View on chart |
| CCS | ▲ Buy | Grant | 2,113 | $0 | 5/8/2024 | View on chart |
| PFIS | ▲ Buy | Grant | 300 | $0 | 1/11/2024 | View on chart |
| CCS | ▲ Buy | Grant | 1,582 | $0 | 10/16/2023 | View on chart |
| PFIS | ▲ Buy | Open Market | 100 | $4K | 5/24/2023 | View on chart |
| PFIS | ▲ Buy | Open Market | 400 | $21K | 2/2/2023 | View on chart |
| PFIS | ▲ Buy | Grant | 285 | $0 | 1/5/2023 | View on chart |
| PFIS | ▲ Buy | Open Market | 500 | $25K | 9/16/2022 | View on chart |
| PFIS | ▲ Buy | Open Market | 200 | $10K | 3/8/2022 | View on chart |
| PFIS | ▲ Buy | Open Market | 830 | $40K | 3/8/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
CCS Expands DFW, Downgrade Noted, Earnings Date Set
The company announced it will acquire HistoryMaker Homes, tripling its Dallas‑Fort Worth presence. Analysts at Seeking Alpha suggested a downgrade as broader market conditions worsen. CCS also set the date for its third‑quarter 2026 earnings release and conference call. The stock is currently near a support level and has an RSI indicating modest momentum.
CCS Expands DFW, Downgrade Noted, Earnings Date Set. The company announced it will acquire HistoryMaker Homes, tripling its Dallas‑Fort Worth presence. Analysts at Seeking Alpha suggested a downgrade as broader market conditions worsen. CCS also set the date for its third‑quarter 2026 earnings release and conference call. The stock is currently near a support level and has an RSI indicating modest momentum.